Chronic Granulomatous Disease Clinical Trial
Official title:
Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995
This study is a longitudinal and cross-sectional evaluation of patients with Chronic Granulomatous Disease (CGD) who received or are receiving hematopoietic cell transplantation (HCT) for their disease under a variety of protocols used by participating institutions compared to a control non-HCT group receiving standard care. Investigators at multiple centers caring for patients with CGD in North America and 3 centers in Europe will participate. Patients with CGD will have been treated according to institutional practice and protocols. Investigators will enroll these patients as subjects in this protocol. This study will investigate which patients benefit most from HCT, and what types of transplants are optimal for patients with CGD, in the context of overall outcomes in CGD patients with and without transplant.
This study is a longitudinal and cross-sectional evaluation of patients with Chronic Granulomatous Disease (CGD) who received or are receiving hematopoietic cell transplantation (HCT) for their disease under a variety of protocols used by participating institutions compared to a control non-HCT group receiving standard care. Investigators at multiple centers caring for patients with CGD in North America and 3 centers in Europe will participate. Patients with CGD will have been treated according to institutional practice and protocols. Investigators will enroll these patients as subjects in this protocol. This study will investigate which patients benefit most from HCT, and what types of transplants are optimal for patients with CGD, in the context of overall outcomes in CGD patients with and without transplant. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT03278912 -
Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations
|
||
| Recruiting |
NCT01652092 -
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
|
N/A | |
| Completed |
NCT04136028 -
IL-1 Receptor Inhibitor for Granulomatous Complications in Patients With Chronic Granulomatous Disease
|
Early Phase 1 | |
| Recruiting |
NCT05687474 -
Baby Detect : Genomic Newborn Screening
|
||
| Terminated |
NCT03080480 -
Pioglitazone Therapy for Chronic Granulomatous Disease
|
Phase 1/Phase 2 | |
| Terminated |
NCT00394316 -
Gene Therapy for Chronic Granulomatous Disease
|
Early Phase 1 | |
| Recruiting |
NCT03910452 -
Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide
|
Early Phase 1 | |
| Terminated |
NCT02282904 -
Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant Cyclophosphamide
|
Phase 1/Phase 2 | |
| Terminated |
NCT02926963 -
Generation of Powerful Biological Tools for Understanding the Pathophysiology of Chronic Granulomatous Disease.
|
N/A | |
| Completed |
NCT00006417 -
Modified Stem Cell Transplantation Procedure for Treating Chronic Granulomatous Disease
|
Phase 2 | |
| Completed |
NCT00368446 -
Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease
|
||
| Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
| Recruiting |
NCT06162936 -
Neutrophil Oxidative Burst in Early and Late Onset Pediatric Inflammatory Bowel Disease
|
||
| Terminated |
NCT05915897 -
Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)
|
||
| Terminated |
NCT00325078 -
Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
|
Phase 1/Phase 2 | |
| Completed |
NCT00001317 -
A Phase IV Study of Recombinant Human Gamma Interferon in Patients With Chronic Granulomatous Diseases of Childhood
|
Phase 4 | |
| Completed |
NCT03548818 -
Role of Interferon-gamma 1-b (IFN-γ) on Cells of the Innate Immune System: Functional, Biochemical and Gene Expression Studies in Patients With Chronic Granulomatous Disease
|
||
| Enrolling by invitation |
NCT06253507 -
pCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)
|
Phase 1/Phase 2 | |
| Recruiting |
NCT01821781 -
Immune Disorder HSCT Protocol
|
Phase 2 | |
| Completed |
NCT00578643 -
Matched Unrelated or Non-Genotype Identical Related Donor Transplantation For Chronic Granulomatous Disease
|
Phase 2 |